John Gu
Interim CEO and Chief Operations Officer
November 21, 2024
Our leadership team has a deep understanding of the pharmaceutical industry, gained through their significant experience in building and operating businesses and major departments within world-leading pharmaceutical, biotechnology and CROs. Our objective is to deliver innovative, cost-effective preclinical and translational research services and tools to power our customers discovery and development programs.
© 2024 Crown Bioscience. All Rights Reserved.
© 2024 Crown Bioscience. All Rights Reserved. Privacy Policy
2024-09-17
2022-12-04
site_page